Drug intelligence / Profile preview

Kang Du Tui Re Formula

Development stage: Unknown
Lead developer: 中国中医科学院望京医院
Administration: Oral

Overview

Kang Du Tui Re Formula is a Traditional Chinese Medicine (TCM) herbal preparation developed by Wangjing Hospital of the China Academy of Chinese Medical Sciences. It is specifically designed to treat fever associated with acute respiratory viral infections. The formula is typically administered as granules and is currently being evaluated in clinical trials for its efficacy in reducing the time to complete fever resolution and improving related clinical outcomes in adult patients. In TCM theory, such formulas are generally intended to clear heat, resolve toxins, and relieve exterior syndromes through the synergistic action of multiple botanical constituents.

Other names: Kangdu Tuire Formula抗毒退热方

Beyond the preview

Go deeper on Kang Du Tui Re Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kang Du Tui Re Formula.

Explore the full profile